Lina_S

About SIOG Head Office

This author has not yet filled in any details.
So far SIOG Head Office has created 420 blog entries.

University of Chicago

2021-07-29T22:38:00+02:00

Geriatrics PD: Kate Thompson Med Onc PD: Kenneth Cohen   Program Opportunities Clinical: 2-3 years of hematology/oncology fellowship and 1 year of geriatrics; also 1 year of palliative medicine, pharmacology, and bioethics are available. Research: Opportunities available on case-by-case basis. Funding available: Funded for clinical fellowships Duration of program: 3-4 years for clinical fellowship Application process: Through ERAS for clinical fellowship; 1-2 additional years for research. Accepts international trainees: No Website

University of Chicago2021-07-29T22:38:00+02:00

Boston University Medical Center

2021-10-21T16:29:54+02:00

Geriatrics PD: Sharon LevineMed Onc PD: Kevan HartshornProgram OpportunitiesClinical: 2-3 years of hematology/oncology fellowship and 1 year of geriatricsResearch: Clinical and basic science research opportunities availableFunding available: Funded for clinical fellowshipDuration of program: 3-4 years for clinical fellowshipApplication process: Through ERAS for clinical fellowshipAccepts international trainees: Contact Geriatrics education office or heme/onc program coordinator regarding specific programs (clinical vs research).Contact person: The Geriatrics Education Office - Phone: +1 617-638-6155, Email: geri.ed@bmc.orgHem/Onc fellowship program coordinator, Anamika Verma - Phone: +1 617-638-7521, Email: Anamika.Verma@bmc.orgWebsite

Boston University Medical Center2021-10-21T16:29:54+02:00

Comorbidity in older adults with cancer

2021-07-29T22:38:01+02:00

Grant R. Williams, Amy Mackenzie, Allison Magnuson, Rebecca Olin, Andrew Chapman, Supriya Mohile, Heather Allore, Mark R. Somerfield, Valerie Targia, Martine Extermann, Harvey Jay Cohen, Arti Hurria, Holly Holmes. Journal of Geriatric Oncology, July 2016 Volume 7, Issue 4, Pages 249–257

Comorbidity in older adults with cancer2021-07-29T22:38:01+02:00

JGO ARTICLE OF THE MONTH – A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer

2021-07-29T22:38:01+02:00

JGO article of the month (most requested article in March 2016) Gerardo Rosati, Giuseppe Aprile, Giovanni Gerardo Cardellino, Antonio Avallone. Journal of Geriatric Oncology Vol. 7, Issue 2, p134–141

JGO ARTICLE OF THE MONTH – A review and assessment of currently available data of the EGFR antibodies in elderly patients with metastatic colorectal cancer2021-07-29T22:38:01+02:00

JGO ARTICLE OF THE MONTH – Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis

2021-07-29T22:38:01+02:00

JGO article of the month (most requested article in December 2015) Chia-Lin Hsu, Jen-Hau Chen, Kuan-Yu Chen, Jin-Yuan Shih, James Chih-Hsin Yang, Chong-Jen Yu, Pan-Chyr Yang. Journal of Geriatric Oncology, Vol. 6, Issue 1

JGO ARTICLE OF THE MONTH – Advanced non-small cell lung cancer in the elderly: The impact of age and comorbidities on treatment modalities and patient prognosis2021-07-29T22:38:01+02:00

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial

2021-07-29T22:38:01+02:00

Hulin C, Belch A, Shustik C, Petrucci MT, Dührsen U, Lu J, Song K, Rodon P, Pégourié B, Garderet L, Hunter H, Azais I, Eek R, Gisslinger H, Macro M, Dakhil S, Goncalves C, LeBlanc R, Romeril K, Royer B, Doyen C, Leleu X, Offner F, Leupin N, Houck V, Chen G, Ervin-Haynes A, Dimopoulos MA, Facon T. J Clin Oncol. 2016 Jun 20. pii: JCO667295. [Epub ahead of print]

Updated Outcomes and Impact of Age With Lenalidomide and Low-Dose Dexamethasone or Melphalan, Prednisone, and Thalidomide in the Randomized, Phase III FIRST Trial2021-07-29T22:38:01+02:00
Go to Top